Ly108 expression distinguishes subsets of invariant NKT cells that help autoantibody production and secrete IL-21 from those that secrete IL-17 in lupus prone NZB/W mice

Journal of Autoimmunity

Volumn 50, Issue , 2014, Pages 87-98

  Tang, Xiaobin ^a   Zhang, Bo ^b   Jarrell, Justin A ^a   Price, Jordan V ^a   Dai, Hongjie ^b   Utz, Paul J ^a   Strober, Samuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Autoantibodies; IL 17; IL 21; Natural killer T cells; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CD150 ANTIGEN; CD19 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 4; LY108 PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; ALPHA-GALACTOSYLCERAMIDE; ANTINUCLEAR ANTIBODY; GALACTOSYLCERAMIDE; INTERLEUKIN DERIVATIVE; LY ANTIGEN; LY108 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL POPULATION; CELL SUSPENSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; HELPER CELL; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; CELL LINEAGE; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; NEW ZEALAND BLACK MOUSE; PATHOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION; SPLEEN;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD19; ANTIGENS, LY; CELL LINEAGE; FEMALE; GALACTOSYLCERAMIDES; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-17; INTERLEUKINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED NZB; NATURAL KILLER T-CELLS; SIGNAL TRANSDUCTION; SPLEEN;

EID: 84899053889     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.01.002     Document Type: Article

References (55)

1. Kotzin B.L. Systemic lupus erythematosus. Cell 1996, 85:303-306.
2. Theofilopoulos A.N., Kofler R., Singer P.A., Dixon F.J. Molecular genetics of murine lupus models. Adv Immunol 1989, 46:61-109.
3. Tsokos G.C. Systemic lupus erythematosus. NEngl J Med 2011, 365:2110-2121.
4. Ando D.G., Sercarz E.E., Hahn B.H. Mechanisms of T and B cell collaboration in the invitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. JImmunol 1987, 138:3185-3190.
5. Borchers A., Ansari A.A., Hsu T., Kono D.H., Gershwin M.E. The pathogenesis of autoimmunity in New Zealand mice. Semin Arthritis Rheum 2000, 29:385-399.
6. Hahn B.H. Antibodies to DNA. NEngl J Med 1998, 338:1359-1368.
7. La Cava A., Fang C.J., Singh R.P., Ebling F., Hahn B.H. Manipulation of immune regulation in systemic lupus erythematosus. Autoimmun Rev 2005, 4:515-519.
8. Takeuchi T. Spontaneous production of antibodies to deoxyribonucleic acids in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1985, 35:47-56.
9. Tsao B.P., Ebling F.M., Roman C., Panosian-Sahakian N., Calame K., Hahn B.H. Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus. JClin Invest 1990, 85:530-540.
10. Mohan C., Adams S., Stanik V., Datta S.K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. JExp Med 1993, 177:1367-1381.
11. Wang A., Batteux F., Wakeland E.K. The role of SLAM/CD2 polymorphisms in systemic autoimmunity. Curr Opin Immunol 2010, 22:706-714.
12. Wandstrat A.E., Nguyen C., Limaye N., Chan A.Y., Subramanian S., Tian X.H., et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 2004, 21:769-780.
13. Kumar K.R., Li L., Yan M., Bhaskarabhatla M., Mobley A.B., Nguyen C., et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 2006, 312:1665-1669.
14. Griewank K., Borowski C., Rietdijk S., Wang N., Julien A., Wei D.G., et al. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 2007, 27:751-762.
15. Hu T., Simmons A., Yuan J., Bender T.P., Alberola-Ila J. The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage. Nat Immunol 2010, 11:435-441.
16. Cannons J.L., Qi H., Lu K.T., Dutta M., Gomez-Rodriguez J., Cheng J., et al. Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 2010, 32:253-265.
17. Qi H., Cannons J.L., Klauschen F., Schwartzberg P.L., Germain R.N. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature 2008, 455:764-769.
18. Zeng D., Liu Y., Sidobre S., Kronenberg M., Strober S. Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus. JClin Invest 2003, 112:1211-1222.
19. Takahashi T., Strober S. Natural killer T cells and innate immune B cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodies. Eur J Immunol 2008, 38:156-165.
20. Morshed S.R., Takahashi T., Savage P.B., Kambham N., Strober S. Beta-galactosylceramide alters invariant natural killer T cell function and is effective treatment for lupus. Clin Immunol 2009, 132:321-333.
21. Zeng D., Lee M.K., Tung J., Brendolan A., Strober S. Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. JImmunol 2000, 164:5000-5004.
22. Forestier C., Molano A., Im J.S., Dutronc Y., Diamond B., Davidson A., et al. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black×New Zealand White)F1 mice. JImmunol 2005, 175:763-770.
23. Chan O.T., Paliwal V., McNiff J.M., Park S.H., Bendelac A., Shlomchik M.J. Deficiency in beta(2)-microglobulin, but not CD1, accelerates spontaneous lupus skin disease while inhibiting nephritis in MRL-Fas(lpr) nice: an example of disease regulation at the organ level. JImmunol 2001, 167:2985-2990.
24. Yang J.Q., Wen X., Liu H., Folayan G., Dong X., Zhou M., et al. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model. Arthritis Rheum 2007, 56:1219-1233.
25. Yang J.Q., Wen X., Kim P.J., Singh R.R. Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner. JImmunol 2011, 186:1512-1520.
26. Wermeling F., Lind S.M., Jordo E.D., Cardell S.L., Karlsson M.C. Invariant NKT cells limit activation of autoreactive CD1d-positive B cells. JExp Med 2010, 207:943-952.
27. Wither J., Cai Y.C., Lim S., McKenzie T., Roslin N., Claudio J.O., et al. Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity. Arthritis Res Ther 2008, 10:R108.
28. Higuchi M., Zeng D., Shizuru J., Gworek J., Dejbakhsh-Jones S., Taniguchi M., et al. Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. JImmunol 2002, 169:5564-5570.
29. Jahng A.W., Maricic I., Pedersen B., Burdin N., Naidenko O., Kronenberg M., et al. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. JExp Med 2001, 194:1789-1799.
30. Zeng D., Lewis D., Dejbakhsh-Jones S., Lan F., Garcia-Ojeda M., Sibley R., et al. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. JExp Med 1999, 189:1073-1081.
31. Morshed S.R., Mannoor K., Halder R.C., Kawamura H., Bannai M., Sekikawa H., et al. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZB×NZW)F1 mice. Eur J Immunol 2002, 32:2551-2561.
32. Coquet J.M., Kyparissoudis K., Pellicci D.G., Besra G., Berzins S.P., Smyth M.J., et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. JImmunol 2007, 178:2827-2834.
33. Spolski R., Leonard W.J. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 2008, 26:57-79.
34. Rankin A.L., Guay H., Herber D., Bertino S.A., Duzanski T.A., Carrier Y., et al. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice. JImmunol 2012, 188:1656-1667.
35. Bubier J.A., Sproule T.J., Foreman O., Spolski R., Shaffer D.J., Morse H.C., et al. Acritical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc Natl Acad Sci U S A 2009, 106:1518-1523.
36. Vinuesa C.G., Cook M.C., Angelucci C., Athanasopoulos V., Rui L., Hill K.M., et al. ARING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005, 435:452-458.
37. Crispin J.C., Kyttaris V.C., Terhorst C., Tsokos G.C. Tcells as therapeutic targets in SLE. Nat Rev Rheumatol 2010, 6:317-325.
38. Yang J., Chu Y., Yang X., Gao D., Zhu L., Wan L., et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009, 60:1472-1483.
39. Zhang Z., Kyttaris V.C., Tsokos G.C. The role of IL-23/IL-17 axis in lupus nephritis. JImmunol 2009, 183:3160-3169.
40. Kang H.K., Liu M., Datta S.K. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. JImmunol 2007, 178:7849-7858.
41. Doreau A., Belot A., Bastid J., Riche B., Trescol-Biemont M.C., Ranchin B., et al. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 2009, 10:778-785.
42. Hsu H.C., Yang P., Wang J., Wu Q., Myers R., Chen J., et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008, 9:166-175.
43. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annu Rev Immunol 2009, 27:485-517.
44. Milpied P., Massot B., Renand A., Diem S., Herbelin A., Leite-de-Moraes M., et al. IL-17-producing invariant NKT cells in lymphoid organs are recent thymic emigrants identified by neuropilin-1 expression. Blood 2011, 118:2993-3002.
45. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011, 29:621-663.
46. Chang P.P., Barral P., Fitch J., Pratama A., Ma C.S., Kallies A., et al. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat Immunol 2012, 13:35-43.
47. Hongo D., Tang X., Dutt S., Nador R.G., Strober S. Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants. Blood 2012, 119:1581-1589.
48. Tabakman S.M., Lau L., Robinson J.T., Price J., Sherlock S.P., Wang H., et al. Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range. Nat Commun 2011, 2:466.
49. Zhang B., Price J., Hong G.S., Tabakman S.M., Wang H.L., Jarrell J.A., et al. Multiplexed cytokine detection on plasmonic gold substrates with enhanced near-infrared fluorescence. Nano Res 2013, 6:113-120.
50. Keszei M., Detre C., Rietdijk S.T., Munoz P., Romero X., Berger S.B., et al. Anovel isoform of the Ly108 gene ameliorates murine lupus. JExp Med 2011, 208:811-822.
51. Chatterjee M., Rauen T., Kis-Toth K., Kyttaris V.C., Hedrich C.M., Terhorst C., et al. Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation. JImmunol 2012, 188:1206-1212.
52. Odegard J.M., Marks B.R., DiPlacido L.D., Poholek A.C., Kono D.H., Dong C., et al. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. JExp Med 2008, 205:2873-2886.
53. Ozaki K., Spolski R., Ettinger R., Kim H.P., Wang G., Qi C.F., et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. JImmunol 2004, 173:5361-5371.
54. Nakou M., Papadimitraki E.D., Fanouriakis A., Bertsias G.K., Choulaki C., Goulidaki N., et al. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells. Clin Exp Rheumatol 2013, 31:172-179.
55. Crispin J.C., Oukka M., Bayliss G., Cohen R.A., Van Beek C.A., Stillman I.E., et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. JImmunol 2008, 181:8761-8766.